Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ALTAREX CORP. (TSE: AXO) -- Ignore unavailable to you. Want to Upgrade?

To: DaveAu who wrote (269)	12/24/2000 11:53:39 AM
From: LAURIE SELINE	Read Replies (1) \| Respond to of 274

Not a big fan of BIOM largely because of that nasty little lawsuit. But I have to admit that those who were patient round about two bucks were well rewarded. Re: Bagley. IMHO he has spent too much time talking up the scientific community and not enough on the investment community. Immune responses are still a bit of a hardsell. But if you consider the insidious nature of cancer and its ability to trick the body into not recognizing its existence this is an interesting avenue to take. Two positives here: DOMPE is associated with AMGEN. And Dlouhy is finally on the buy side. All the best in 2001. L.